Status:
RECRUITING
Diagnostic Interest of Bone Tomoscintigraphy in the Search for Cervical Pseudarthrosis
Lead Sponsor:
Ramsay Générale de Santé
Conditions:
Cervical Pseudarthrosis
Eligibility:
All Genders
21-99 years
Phase:
NA
Brief Summary
Cervical pseudarthrosis is a classic complication and a challenge for challenge for spine surgeons. The rate of pseudarthrosis can range from 3 to 15%, and depend greatly on the patient, the approach ...
Eligibility Criteria
Inclusion
- Patients over 21 years of age
- Patients who have undergone cervical arthrodesis and are being treated at Clinique de la Sauvegarde or Clinique Convert
- Patients with a NDI clinical score at 1 year greater than 5
- Patient affiliated to/ or beneficiary of a Social Security scheme as definied by the law
Exclusion
- Patients whose clinical condition requires rapid treatment that can't wait for examinations to be carried out
- Pregnancy and breastfeeding
- Protected person (curatorship, guardianship, safeguard of justice)
- History of hypersensitivity to the active substance ( sodium oxidronate) or to any of its constituents
Key Trial Info
Start Date :
December 31 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07140432
Start Date
December 31 2024
End Date
February 28 2027
Last Update
August 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Convert ( INA)
Bourg-en-Bresse, France, 01000